Thank you, Stefanie.
quiet second might June. procedure been most to volumes customer more sequential for the we but Like in push This restart are that here has suggests quarter. substantial industry, base improvement was our in still a the experience April, reduction us our to May during our very in within we and see expecting which monthly
quarter, will The last and of third we perhaps quarter the procedure by down year will see the compared fourth normal also of more to be likely level third quarter activity. a
needs. measures reduction we step initial capital, As support have to aggressive demand monitor outlined customer we in took any the to retained cost flexibility also the preserve signals emerging
Company thrive to make again normal. when Additionally, position to the we are the returns to investments continuing to key market
these I'm update on of take to efforts. the going minutes couple next of you continuing some to
comparing make to Gastroplasty progress. Endoscopic for procedure reimbursement expansion. ESG lifestyle MERIT Sleeve the to First piece procedure and the label key trial also trial strategy a nine-center the our randomized management managed prospective ESG medically is supports or of This continues
investigator level In late all procedures. completed the XXXX, one sites
of crossover than past procedures more completed. week, this are As XX% of the
With COVID-XX MERIT adapt resident order Apollo our the up COVID-XX. cities, platform needs. the by support primarily all being in began telehealth In trial remaining patients investigator use sites the to Care quarter U.S. their patient recurring hardest in hit to to they follow to situation, were crossovers first MERIT
interactive patients and stay patient in is their follow-up, our in determine could and with physician current Apollo tool and the place that of for telehealth very are practices be engage potentially while Care investigators beyond. and helpful and to guidelines place ideal the shelter home at progress enables this MERIT follow
This as to development channel Endoscopy, collaborate quarter GI grant provided the to of the and part American Endoscopic Second, launched suturing ASGE's an now learning channel. Apollo the offered in the XXXX, or in educational of the portal. is on ASGE, first Society for was Gastrointestinal Leap online an
Leap the learning. ASGE's is online experience GI modern features the delays foundation The learning Leap of learner all educational give online the GI ASGE's for online of home the optimal of advanced learning offerings. technological platform a future GI to
suturing applications three as suturing U.S. have XX procedural GI been available GI techniques physicians The than that and the has in videos this across channel Endoscopic Leap advanced bariatric of highlight more includes applications. well variety primary revisional closure, and clinical as wide channel a months endoscopic suturing In XX registered.
collaboration very been with our ESS ASGE been continues our has education to and a education important medical the Medical mission. success this has advance to very,
again platform work in-person once endoscopic United training Moving add our further is Leap ASGE more forward, develop the and GI virtual to We outside supplement with plan to the States an an to continent medical physicians attractive to we robust channel. resources medical education offer content in option. their see as to suturing person education ASGE's traditional
this invest tract. to this work of advancement important to of colon. suturing fix the today, to on Lastly, meaningful we lower to in for offer are project. Based better the product benefits - endoluminal we the complex elements offers of GI two this are continuing new think a closure development the will There in bring preclinical
expand market for the endoluminal expect First, will new the we addressable suturing. product
upper our primarily due know procedures product current you of line. length most portfolio used OverStitch product GI the As to of will our current is in
in Within prevalent market, per U.S. the for represents represents XX% for is GI closure GI us. upper of alone, need there it In lower opportunity tract. tract are a year upper about the market the broad as market, GI the the the performed as is lower XX the endoscopic significant in over tract GI endoscopy and procedure colonoscopies million overall and thus the
address will is given Second, the the most endoscope the technical reason name over or of it that need requires flexible very which a device to a know portfolio also OverStitch externally was with. product as to device is will attached current ESS our the important you begin
to this prior requires suturing the requires For core this reorient and of to remove attach to ESS endoscope, the a either scope, physician planned use insertion the GI applications, desire. back or our tract and physician suturing scope it GI the to re-unserved the to device area then a
Our designed efficiency the of of new core provide product offering physician this desired. and suturing to is the with suture improve ability when the through is procedures endoscope, the will lumen many GI the to
always currently some we of is GI potential that the development belief available to be product are but uncertainty There a the late lower this to product U.S. timeline, market year. has new in the the
that, Christie, please read now - session. for we'll And open lines questions-and-answer with the to proceed.
